Vimarsana
Biggest News Aggregation in the World

Sheena Berry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sheena Berry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sheena Berry Today - Breaking & Trending Today

AstraZeneca's blockbuster lung cancer drug boosts survival rates among patients, pharma giant says - Vimarsana News

AstraZeneca's blockbuster lung cancer drug boosts survival rates among patients, pharma giant says

In a shot in the arm for the FTSE 100 group, a trial revealed that Imfinzi showed promise in treating highly aggressive small cell lung cancer.

AstraZeneca's blockbuster lung cancer drug boosts survival rates among patients, pharma giant says - Vimarsana News

AstraZeneca's blockbuster lung cancer drug boosts survival rates among patients, pharma giant says

In a shot in the arm for the FTSE 100 group, a trial revealed that Imfinzi showed promise in treating highly aggressive small cell lung cancer.

How investors can make gains from the weight-loss trend - Vimarsana News

How investors can make gains from the weight-loss trend

Huge gains are expected from the weight loss market, we explain how to investing in this growing sector

Trending : GSK's 3Q Profits Drive Full-Year Guidance Hike, Despite Missing Market Views -November 01, 2023 at 08:04 am EDT - Vimarsana News

Trending : GSK's 3Q Profits Drive Full-Year Guidance Hike, Despite Missing Market Views -November 01, 2023 at 08:04 am EDT

1147 GMT - GSK is among the most mentioned companies across news items over the past five hours, according to Factiva data. The British pharmaceutical giant on Wednesday hiked full-year guidance as...

Stock Spotlight: US drug price negotiation not an immediate threat to Pfizer - Vimarsana News

Stock Spotlight: US drug price negotiation not an immediate threat to Pfizer

The US Government has named the first ten drugs eligible for price negotiation with Medicare from 2026, which include Pfizer’s products.